板块轮动观察 16/03/2023 关注股份📊 药品:信达生物(1801)

港股短评

经过两日上冲下洗之后,恒指回稳,昨日最高曾高见19745,其后回顺至19539点收市。市场开始消化美国硅谷银行的负面影响,不过瑞信事件又刮起另一股寒风,夜期曾跌至19025点,虽然尾市回升至19230 ,留意250天线未能收复,大市再度寻底的机会较大。

https://business.facebook.com/%E8%82%A1%E4%BD%A0%E5%94%94%E5%88%B0-232673967110384/

 

以上内容并非亦不应被视为投资建议,只作为资料性及一般用途,投资者应考虑自己个人需要、投资目标及特定财政状况,本内容不构成据以所作任何行动的要约、邀请、建议或招揽。

Facebook
WhatsApp
Twitter

Notification


About false information on the internet

Recent spreading false information on some social platforms, including statement that Silverbricks Securities is unable to withdraw funds and has subscribed for the initial public offering of Guomai Culture&Media Co.,Ltd. (301052). We, hereby, make the following declaration .

Our company is supervised by the Securities and Futures Commission of Hong Kong(SFC). Our finances are sound and has no issues with deposits and withdrawals. Meanwhiles, we does not subscribe any shares of Guomai Culture&Media Co.,Ltd. (301052)

Our company condemns this untrue remarks and reserves the right to pursue legal liabilities. If customers have any questions, please call our company for inquiries, Tel: 3998 5120

元库证券有限公司

SILVERBRICKS SECURITIES COMPANY LIMITED